Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

NCT: NCT05755711 · ACTIVE_NOT_RECRUITING

NCT IDNCT05755711
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-03
Completion2028-04

Brief Summary

Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.

Frequently Asked Questions

What is Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease?

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease is a clinical trial registered under NCT05755711. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05755711?

The current status of NCT05755711 (Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease) is: ACTIVE_NOT_RECRUITING.

When did Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease start?

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease started on 2023-05-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.